1Masayoshi YO,Yukihiro N,Toshinari T,et al.Inhibiyory effect of troglitazone in tumor necrosis factor alpha induced expression of monocyte chemattractant protion 1 in human mesagial ceels.Metabolism,2000,49:163-165.
2Haslinger B,Mand-weber S,Sellmager A ,et al.Effect of high glucose concentration on the synthesis of monocyte chemoattractant protein-1 in human perineal mesothelial cells:involvement of protein kinase.Nephron,2001,87(4):346-351.
3Juan F Navarro JF,Mora C,Macia M,et al. Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus.Am J Kidney Dis,2003,42(1):53-55.
4Joles JA,Kunter U,Janssen U,et al.Early mechanisms of renal injury in hypercholesterolemic or hypertriglyceridemic rats. J Am Soc Nephrol,2000,11:669-683.
5Kodama N, Otani H, Yamada Y, et al. Involvement of MCP-1 and M-CSF in glomerular foam cell formation in ExHC rats. Kidney Int Suppl,1999,71:174-177.
7Utimura R,Fujihara CK,Mattar AL,et al.Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes.Kid Int,2003,63:209-216.
8Allison AC,Eugui EM. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology,2000,47(2-3):85-118.
9Frolich M,Imhof A,Berg G,et al.Association between C-reactive protein and features of the metabolic syndrome. Diabetes Care, 2000, 23:1835-1839.
10Festa A,D Agostion R,Howard G, et al.Chronic subclinical inflammation as part of the insulin resistance syndrome. Circulation, 2000,102:42-47.
二级参考文献8
1Ishidoya S,Morrissey J,McCracken R,et al.Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy[].Kidney International.1996
2Zoja C,Morigi M,Figliuzzi M,et al.Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins[].American Journal of Kidney Diseases.1995
3Sintchak MD,Fleming MA,Futer 0,et al.Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid[].Cell.1996
4Sollinger HW.Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients.U. S. Renal Transplant Mycophenolate Mofetil Study Group[].Transplantation.1995
5Ruth Z,Steinmann-niggli K,Kappeler A,et al.Mycophenolic acid: a new approach to therapy of experimental mesangial proliferative glomerulonephritis[].Journal of the American Society of Nephrology.1998
6Cherif B,Vincent M,McGregor B,et al.Mycophenolate mofetil reduces myofibroblast infiltration and collgen Ⅲ deposition in rat remnant kidney[].Kidney International.2000
7Corna D,Morigi M,Facchinetti D,et al.Mycophenolate mofetil limits renal damage and prolongs life in murine lupus autoimmune disease[].Kidney International.1997
8Raisanen-Sokolowski A,Vuoristo P,MyllArniemi M,et al.Mycophenolate mofetil(MMF, RS-61443) inhibits inflammation and smooth muscle cell proliferation in rat aortic allografts[].Transplant Immunology.1995
7Tilak P,Khashim Z,Kumpatla S,et al. Clinical significance of urinary Monocyte Chemoattractant Protein 1 (uMCP-1) in Indian type 2 diabetic patients at different stages of diabetic nephropathy[J]. Int J of Diabetes Mellitus,2010,2(1) : 15-19.
8Chow F, Nikolic-Paterson D, Ozols E, et al. Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice [J]. J Am Soc Nephrol, 2005, 16 ( 6 ) 1711-1722.
9Wu Y, Dong J, Yuan L,et al. Nephrin and podocin loss is prevented by myeophenolate mofetil in early experimental diabetic nephropathy[J]. Cytokine,2008,44(1) :85-91.
10Usui H, Shikata K, Matsuda M, et al. HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats[J]. Nephrol Dial Transplant, 2003,18 (2) : 265-272.
